Literature DB >> 2903365

Idiopathic thrombocytopenia treated with Paf-acether antagonist WEB 2086.

H F Lohmann, W S Adamus, C J Meade.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2903365     DOI： 10.1016/s0140-6736(88)90572-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Failure of the platelet-activating-factor antagonist WEB 2086 BS for treatment of chronic autoimmune thrombocytopenia.

Authors:  G Giers; H Janzarik; E R Kempe; C Mueller-Eckhardt
Journal:  Blut       Date:  1990-07

2.  Platelet-activating factor type activity in plasma from patients with septicemia and other diseases.

Authors:  H O Heuer; H Darius; H F Lohmann; J Meyer; M Schierenberg; N Treese
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

3.  Growth inhibition and differentiation of human breast cancer cells by the PAFR antagonist WEB-2086.

Authors:  C Cellai; A Laurenzana; A M Vannucchi; R Caporale; M Paglierani; S Di Lollo; A Pancrazzi; F Paoletti
Journal:  Br J Cancer       Date:  2006-06-05       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.